Literature DB >> 10185375

Decision analysis in the selection, design and application of clinical and health services research.

R Lilford1, G Royston.   

Abstract

Research evidence will never be sufficient to tell us how treatments compare in every group or class of patients. It will always be necessary to particularize from the general to the specific. The ad hoc way this is normally done contrasts with the rigour of the research process. However, extrapolating from the general to the particular can be made equally rigorous by Decision Analytic modelling. Furthermore, research evidence is not enough when decisions turn on multiple objectives, which must be traded off against each other. Research evidence and patients' preferences can be reconciled, again rigorously, by using Decision Analysis to show how probabilities and values interact. In addition, research should be designed around likely clinical impact, and this in turn can be made explicit by Decision Analytic modelling. In particular, sample size calculations should be based on such explicit modelling, rather than current procedures, which seldom seek to defend the size of clinical effects sought.

Entities:  

Mesh:

Year:  1998        PMID: 10185375     DOI: 10.1177/135581969800300307

Source DB:  PubMed          Journal:  J Health Serv Res Policy        ISSN: 1355-8196


  6 in total

Review 1.  Randomised controlled trials in primary care: case study.

Authors:  S Wilson; B C Delaney; A Roalfe; L Roberts; V Redman; A M Wearn; F D Hobbs
Journal:  BMJ       Date:  2000-07-01

2.  Evidence based policy: proceed with care.

Authors:  N Black
Journal:  BMJ       Date:  2001-08-04

3.  Keeping pace with new technologies: systems needed to identify and evaluate them.

Authors:  A Stevens; R Milne; R Lilford; J Gabbay
Journal:  BMJ       Date:  1999-11-13

4.  Withdrawing low risk women from cervical screening programmes: mathematical modelling study.

Authors:  C Sherlaw-Johnson; S Gallivan; D Jenkins
Journal:  BMJ       Date:  1999-02-06

5.  Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation.

Authors:  Richard Thomson; Angela Robinson; Jane Greenaway; Philip Lowe
Journal:  Qual Saf Health Care       Date:  2002-03

6.  Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain.

Authors:  Jose Martinez-Raga; Francisco Gonzalez-Saiz; Julian Oñate; Itziar Oyagüez; Eliazar Sabater; Miguel A Casado
Journal:  Health Econ Rev       Date:  2012-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.